Insights into the role of fibroblasts in human autoimmune diseases

Clinical and Experimental Immunology

Volumn 141, Issue 3, 2005, Pages 388-397

  Smith, Terry J ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune; Cytokine; Fibroblasts; Inflammation

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; SOMATOMEDIN C; THYROTROPIN RECEPTOR;

AUTOIMMUNE DISEASE; CELL ACTIVITY; CYTOKINE PRODUCTION; FIBROBLAST; GRAVES DISEASE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ORBIT; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE REACTION; TISSUE STRUCTURE;

ANTIGENS, CD40; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CD40 LIGAND; CYTOKINES; FIBROBLASTS; GRAVES DISEASE; HUMANS; ORBIT; RECEPTOR, IGF TYPE 1; RECEPTORS, THYROTROPIN; SYNOVIAL MEMBRANE;

EID: 23044448407     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02824.x     Document Type: Review

References (109)

1. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000; 2:361-7.
2. Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10:366-91.
3. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13:7-12.
4. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells: synthesis of chemokines and regulation of inflammation. Am J Pathol 1997; 151:317-22.
5. Sweeney SE, Firestein GS. Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 2004; 36:372-8.
6. Smith TJ. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity 2003; 36:409-15.
7. Smith TJ. Fibroblast biology in thyroid diseases. Curr Opin Endocrinol Diabetes 2002; 9:393-400.
8. Bahn RS. Pathophysiology of Graves' ophthalmopathy: the cycle of disease. Clinical review 157. J Clin Endocrinol Metab 2003; 88:1939-46.
9. Henrikson RC, Smith TJ. Ultrastructure of cultured human orbital fibroblasts. Cell Tissue Res 1994; 278:629-31.
10. Castor CW, Prince RK, Dorstewitz EL. Characteristics of human 'fibroblasts' cultivated in vitro from different anatomical sites. Lab Invest 1962; 11:703-13.
11. Schneider EL, Mitsui Y, Au KS, Shorr SS. Tissue-specific differences in cultured human diploid fibroblasts. Exp Cell Res 1977; 108:1-6.
12. Pinsky L, Finkelberg R, Straisfeld C, Zilahi B, Kaufman M, Hall G. Testosterone metabolism by serially subcultured fibroblasts from genital and nongenital skin of individual human donors. Biochem Biophys Res Commun 1972; 46:364-9.
13. Hassell TM, Page RC, Narayanan AS, Cooper CG. Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. Proc Natl Acad Sci USA 1976; 73:2909-12.
14. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432:332-7.
15. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27:549-50.
16. Bordin S, Kolb WP, Page RC. C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties. J Immunol 1983; 130:1871-5.
17. Borrello MA, Phipps RP. Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol 1996; 173:198-206.
18. Fries KM, Blieden T, Looney RJ et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994; 72:283-92.
19. Morris RJ, Ritter MA. Association of Thy-1 cell surface differentiation antigen with certain connective tissues in vivo. Cell Tissue Res 1980; 206:459-75.
20. 3, on astrocytes and triggers formation of focal contact sites. Curr Biol 2001; 11:1028-38.
21. Hagood JS, Mangalwadi A, Guo B, MacEwen MW, Salazar L, Fuller GM. Concordant and discordant interleukin-1-mediated signaling in lung fibroblast Thy-1 subpopulations. Am J Respir Cell Mol Biol 2002; 26:702-8.
22. Zhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 2004; 165:659-69.
23. - subpopulations exhibit distinct phenotypes. Eur J Immunol 2002; 32:477-85.
24. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP. Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. Am J Pathol 2001; 159:925-35.
25. Muller-Ladner U, Gay RE, Gay S. Structure and function of synoviocytes. In: Arthritis and allied conditions. A textbook of rheumatology. Baltimore: Williams & Wilkins 1997:243-54.
26. Goto M, Sasano M, Yamanaka H et al. Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 1987; 80:786-96.
27. Sciaky D, Brazer W, Center DM, Cruikshank WW, Smith TJ. Cultured human fibroblasts express constitutive IL-16 mRNA. Cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol 2000; 164:3806-14.
28. Pierer M, Rethage J, Seibl R et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004; 172:1256-65.
29. Pritchard J, Tsui S, Horst N, Cruikshank WW, Smith TJ. Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with immunoglobulins against the IGF-1 receptor. J Immunol 2004; 173:3564-9.
30. Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996; 17:476-81.
31. Crofford LJ, Wilder RL, Ristimaki AP et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-toid 1 beta, phorbol ester, and corticosteroids. J Clin Invest 1994; 93:1095-101.
32. Stichtenoth DO, Thoren S, Bian H, Peters-Golden M, Jakobsson PJ, Crofford LJ. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol 2001; 167:469-74.
33. Smith TJ. Cyclooxygenases as the principal targets for the actions of non-steroidal anti-inflammatory drugs. Rheum Dis Clin North Am 1998; 24:501-23.
34. Han Z, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 1998; 28:197-208.
35. Miagkov AV, Kovalenko DV, Brown CE et al. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998; 95:13859-64.
36. Asahara H, Fujisawa K, Kobata T et al. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum 1997; 40:912-8.
37. Kontny E, Ziolkowska M, Dudzinka E, Filipowicz-Sosnowska A, Ryzewska A. Modified expression of c-Fos and c-Jun proteins and production of interleukin-1 beta in patients with rheumatoid arthritis. Clin Exp Rheumatol 1995; 13:51-7.
38. Dooley S, Herlitzka I, Hanselmann R et al. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis 1996; 55:298-304.
39. Schett G, Tohidast-Akrad M, Smolen JS et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000; 43:2501-12.
40. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2000; 2:59-64.
41. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 1997; 94:10895-900.
42. Weetman AP. Graves' disease. N Engl J Med 2000; 343:1236-48.
43. Weetman AP. Determinants of autoimmune thyroid disease. Nat Immunol 2001; 2:769-70.
44. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid associated orbitopathy: evolving rationale for therapy. Arch Ophthal 2002; 120:380-6.
45. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 2003; 24:802-35.
46. Smelser GK. The histology of orbital and other fat tissue deposits in animals with experimentally produced exophthalmos. Am J Pathol 1939; 15:341-51.
47. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984; 91:1411-9.
48. Young DA, Evans CH, Smith TJ. Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical-site-restricted cytokine-target cell interactions. Proc Natl Acad Sci USA 1998; 95:8904-9.
49. Smith TJ, Bahn RS, Gorman CA. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J Clin Endocrinol Metab 1989; 69:1019-23.
50. 2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves' ophthalmopathy. Proc Natl Acad Sci USA 1994; 91:5094-8.
51. Sorisky A, Pardasani D, Gagnon A, Smith TJ. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 1996; 81:3428-31.
52. Kumar S, Coenen MJ, Scherer PE, Bahn RS. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 2004; 89:930-5.
53. Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M. Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 2000; 41:3249-55.
54. Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab 1995; 80:2620-5.
55. Smith TJ, Koumas L, Gagnon A et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2002; 87:385-92.
56. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 2003; 163:1291-300.
57. Ajjan RA, Weetman AP. New understanding of the role of cytok-ines in the pathogenesis of Graves' ophthalmopathy. J Endocrinol Invest 2004; 27:237-45.
58. Wang H-S, Cao HJ, Winn VD et al. Leukoregulin induction of prostaglandin endoperoxide H synthase-2 in human orbital fibroblasts: an in vitro model for connective tissue inflammation. J Biol Chem 1996; 271:22718-28.
59. Cao HJ, Wang H-S, Zhang Y, Lin H-Y, Phipps RP, Smith TJ. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression: Insights into potential pathogenic mechanisms of thyroid associated ophthalmopathy. J Biol Chem 1998; 273:29615-25.
60. 2 synthase expression. J Biol Chem 2002; 277:16355-64.
61. Cao HJ, Han R, Smith TJ. Robust induction of PGHS-2 by IL-1in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression. Am J Physiol Cell Physiol 2003; 284:C1429-37.
62. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146:108-13.
63. 2 on murine helper-T-cell lymphokines. Immunomethods 1993; 2:255-60.
64. Brown DM, Warner GL, Ales-Martinez JE, Scott DW, Phipps RP. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clin Immunol Immunopathol 1992; 63:221-9.
65. Hu ZQ, Asano K, Seki H, Shimamura T. An essential role of prostaglandin E on mouse mast cell induction. J Immunol 1995; 155:2134-42.
66. 2 alters human orbital fibroblast shape through a mechanism involving the generation of cyclic adenosine monophosphate. J Clin Endocrinol Metab 1995; 80:3553-60.
67. Smith TJ, Bahn RS, Gorman CA, Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J Clin Endocrinol Metab 1991; 72:1169-71.
68. Smith TJ, Wang HS, Evans CH. Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. Am J Physiol Cell Physiol 1995; 268:C382-8.
69. Spicer AP, Kaback LA, Smith TJ, Seldin MF. Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes. J Biol Chem 1998; 273:25117-24.
70. Smith TJ, Hoa N. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, IGF-1 receptor. J Clin Endocrinol Metab 2004; 89:5076-80.
71. Kaback LA, Smith TJ. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1β in human orbital fibroblasts. Potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 1999; 84:4079-84.
72. Smith TJ. Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts: similar effects of glucocorticoid and thyroid hormones. J Clin Invest 1984; 74:2157-63.
73. Smith TJ, Ahmed A, Hogg MG, Higgins PJ. Interferon-gamma is an inducer of plasminogen activator inhibitor type 1 in human orbital fibroblasts. Am J Physiol 1992; 263:C24-9.
74. Cao H, Hogg MG, Martino LJ, Smith TJ. Transforming growth factor-β induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts. Invest Ophthalmol Vis Sci 1995; 36:1411-9.
75. Hogg MG, Evans CH, Smith TJ. Leukoregulin induces plasminogen activator inhibitor type 1 in human orbital fibroblasts. Am J Physiol 1995; 269:C359-66.
76. Smith TJ, Higgins PJ. Interferon gamma regulation of de novo protein synthesis in human dermal fibroblasts in culture is anatomic site-dependent. J Invest Dermatol 1993; 100:288-92.
77. Han R, Smith TJ. Induction by IL-1β of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and interferon γ. J Immunol 2005; 174:3072-9.
78. Heufelder AE, Bahn RS. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy. Clin Exp Immunol 1993; 91:381-9.
79. Heufelder AE, Bahn RS. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clin Exp Immunol 1993; 92:296-302.
80. Heufelder AE, Bahn RS. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest 1992; 22:529-37.
81. Mauviel A, Redini F, Hartmann DJ, Pujol JP, Evans CH. Modulation of human dermal fibroblast extracellular matrix metabolism by the lymphokine leukoregulin. J Cell Biol 1991; 113:1455-62.
82. Muhlberg T, Heberling HJ, Joba W, Schworm HD, Heufelder AE. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts. Invest Ophthalmol Vis Sci 1997; 38:1018-28.
83. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV, Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993; 342:337-8.
84. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M. Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 1997; 82:2003-5.
85. Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M. Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol 2003; 30:369-80.
86. Wu SL, Yang CS, Wang HJ, Liao CL, Chang TJ, Chang TC. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization. J Endocrinol Invest 1999; 22:289-95.
87. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 1998; 83:998-1002.
88. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 2000; 279:C335-40.
89. Agretti P, Chiovato L, De Marco G et al. Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol 2002; 147:733-9.
90. Klein JR. Physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tissues other than the thyroid. Autoimmunity 2003; 36:417-21.
91. Valyasevi RW, Erickson DZ, Harteneck DA et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 1999; 84:2557-62.
92. Jyonouchi SC, Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy. Thyroid 2001; 11:929-34.
93. Paschke R, Vassart G, Ludgate M. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 1995; 42:565-9.
94. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12:881-922.
95. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89:6550-4.
96. Kaufman J, Sime PJ, Phipps RP. Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol 2004; 172:1862-71.
97. Brouty-Boye D, Pottin-Clemenceau C, Doucet C, Jasmin C, Azzarone B. Chemokines and CD40 expression in human fibroblasts. Eur J Immunol 2000; 30:914-9.
98. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP. CD40 expression by human fibroblasts. Clin Immunol Immunopathol 1995; 77:42-51.
99. Sempowski GD, Chess PR, Moretti AJ, Padilla J, Phipps RP, Blieden TM. CD40 mediated activation of gingival and periodontal ligament fibroblasts. J Periodontol 1997; 68:284-92.
100. Sempowski GD, Chess PR, Phipps RP. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997; 158:4670-7.
101. Wassenaar A, Verschoor T, Kievits F et al. CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin Exp Immunol 1999; 115:161-7.
102. Zhang Y, Cao HJ, Graf B, Meekins H, Smith TJ, Phipps RP. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J Immunol 1998; 160:1053-7.
103. Sempowski GD, Rozenblit J, Smith TJ, Phipps RP. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol Cell Physiol 1998; 274:C707-14.
104. Yellin MJ, Winikoff S, Fortune SM et al. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukoc Biol 1995; 58:209-16.
105. Rissoan MC, Van Kooten C, Chomarat P et al. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol 1996; 106:481-90.
106. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2003; 59:207-13.
107. Pritchard J, Horst N, Cruikshank W, Smith TJ. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 2002; 168:942-50.
108. Weightman DR, Perros P, Sherif IH, Kendall-Taylor P. Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. Autoimmunity 1993; 16:251-7.
109. Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the IGF-1 receptor pathway. J Immunol 2003; 170:6348-54.